TURPTURP
as diagnostic measure ofas diagnostic measure of
Prostate CancerProstate Cancer
Oral presentation at the Meeting
of Okinawa Urologists (Naha-city, Japan, 2004)004)
Vladimir Startsev,Vladimir Startsev, M.D.,
Urology Department, Regional Oncological Hospital
St.-Petersburg, Russia
PurposePurpose
To determine whether evaluation of TURPTo determine whether evaluation of TURP
could detectcould detect prostate cancerprostate cancer
missed by routinemissed by routine
US-GuidedUS-Guided sextant prostate biopsiessextant prostate biopsies
9898 patientspatients
(median age 66,4 y.o.)
with LUTSwith LUTS andand
tPSAtPSA levellevel 5-125-12 ng/mL
All persons underwent
systematic
US-guided sextant
PZ - biopsiesPZ - biopsies
Our post-biopsy resultsOur post-biopsy results
Positive (+)Positive (+)
specimensspecimens
2828 cases of
prostate cancer
Negative (-)Negative (-)
specimensspecimens
   7070 cases
28.6%28.6% 71.4%71.4%
TURP to all patientsTURP to all patients
withwith negative (-) specimensnegative (-) specimens andand
indications to reliefindications to relief LUTSLUTS && BNOBNO (n=49)(n=49)
Prostate cancer
in 12 (24.5%)in 12 (24.5%)
- organ-confined
- Gleason score < 5
- <10 % of resected tissue
4 - RRP,
8 – MAB (Zoladex+Androcur) +RBT
Follow-up 6 monthFollow-up 6 month
of non - operated,of non - operated,
(-) specimens patients(-) specimens patients (n=21)(n=21)
tPSAtPSA level increase in 77 (33.3%33.3%) cases,
7 second US-G biopsies
Prostate Cancer in 4 (19.0%) cases
( 4 RRP performed)
Summarized schemaSummarized schema
98 US-Guided biopsies
28.6% 71.4%
TURP n=49 Medicine n=21
24.5%24.5%
19.0%19.0%
1212
44
DiscussionDiscussion
Specificity of routine US-guided prostateSpecificity of routine US-guided prostate
biopsy is not high enough, using thisbiopsy is not high enough, using this
procedure is not warranted for cancerprocedure is not warranted for cancer
detection.detection.
DiscussionDiscussion
 TURP can detect cancer also in TZ of theTURP can detect cancer also in TZ of the
prostate, while treating LUTS with BNOprostate, while treating LUTS with BNO
 in patients with negative biopsyin patients with negative biopsy
specimens.specimens.
ConclusionConclusionss
TURP is necessary forTURP is necessary for all patients withall patients with
severe LUTS (BNO associated)severe LUTS (BNO associated)
and negative prostate biopsies.and negative prostate biopsies.
ConclusionConclusionss
Now we performNow we perform octant (n=8 cores)octant (n=8 cores)
US-Guided prostate biopsies.US-Guided prostate biopsies.
Do all we must?Do all we must?
Thank you for attention!Thank you for attention!
St.-Petersburg,
Russia, 2004
Vladimir Startsev
http://www.urostar.ru

Resection of the prostate

  • 1.
    TURPTURP as diagnostic measureofas diagnostic measure of Prostate CancerProstate Cancer Oral presentation at the Meeting of Okinawa Urologists (Naha-city, Japan, 2004)004) Vladimir Startsev,Vladimir Startsev, M.D., Urology Department, Regional Oncological Hospital St.-Petersburg, Russia
  • 2.
    PurposePurpose To determine whetherevaluation of TURPTo determine whether evaluation of TURP could detectcould detect prostate cancerprostate cancer missed by routinemissed by routine US-GuidedUS-Guided sextant prostate biopsiessextant prostate biopsies
  • 3.
    9898 patientspatients (median age66,4 y.o.) with LUTSwith LUTS andand tPSAtPSA levellevel 5-125-12 ng/mL All persons underwent systematic US-guided sextant PZ - biopsiesPZ - biopsies
  • 4.
    Our post-biopsy resultsOurpost-biopsy results Positive (+)Positive (+) specimensspecimens 2828 cases of prostate cancer Negative (-)Negative (-) specimensspecimens    7070 cases 28.6%28.6% 71.4%71.4%
  • 5.
    TURP to allpatientsTURP to all patients withwith negative (-) specimensnegative (-) specimens andand indications to reliefindications to relief LUTSLUTS && BNOBNO (n=49)(n=49)
  • 6.
    Prostate cancer in 12(24.5%)in 12 (24.5%) - organ-confined - Gleason score < 5 - <10 % of resected tissue 4 - RRP, 8 – MAB (Zoladex+Androcur) +RBT
  • 7.
    Follow-up 6 monthFollow-up6 month of non - operated,of non - operated, (-) specimens patients(-) specimens patients (n=21)(n=21) tPSAtPSA level increase in 77 (33.3%33.3%) cases, 7 second US-G biopsies Prostate Cancer in 4 (19.0%) cases ( 4 RRP performed)
  • 8.
    Summarized schemaSummarized schema 98US-Guided biopsies 28.6% 71.4% TURP n=49 Medicine n=21 24.5%24.5% 19.0%19.0% 1212 44
  • 9.
    DiscussionDiscussion Specificity of routineUS-guided prostateSpecificity of routine US-guided prostate biopsy is not high enough, using thisbiopsy is not high enough, using this procedure is not warranted for cancerprocedure is not warranted for cancer detection.detection.
  • 10.
    DiscussionDiscussion  TURP candetect cancer also in TZ of theTURP can detect cancer also in TZ of the prostate, while treating LUTS with BNOprostate, while treating LUTS with BNO  in patients with negative biopsyin patients with negative biopsy specimens.specimens.
  • 11.
    ConclusionConclusionss TURP is necessaryforTURP is necessary for all patients withall patients with severe LUTS (BNO associated)severe LUTS (BNO associated) and negative prostate biopsies.and negative prostate biopsies.
  • 12.
    ConclusionConclusionss Now we performNowwe perform octant (n=8 cores)octant (n=8 cores) US-Guided prostate biopsies.US-Guided prostate biopsies. Do all we must?Do all we must?
  • 13.
    Thank you forattention!Thank you for attention! St.-Petersburg, Russia, 2004 Vladimir Startsev http://www.urostar.ru